Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease - Sullivan, Kelly L.; Staffetti, Joseph F.; Hauser, Robert A.; Dunne, Peter B.; Zesiewicz, Theresa A. (Movement disorders, 2006)
Keywords: Aged; Biological and medical sciences; constipation; Constipation - drug therapy; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases; Double-Blind Method; Female; Gastrointestinal Agents - administration & dosage; Gastrointestinal Motility - drug effects; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy; Humans; Indoles - administration & dosage; Male; Medical sciences; Middle Aged; Nervous system (semeiology, syndromes); Neurology; Parkinson Disease - drug therapy; Parkinson's disease; Patient Satisfaction; Serotonin 5-HT4 Receptor Agonists; Serotonin Receptor Agonists - administration & dosage; tegaserod; Zelnorm; Nervous system diseases; Parkinson's disease; Parkinson disease; Cerebral disorder; Zelnorm; Treatment; Central nervous system disease; Digestive diseases; Intestinal disease; Degenerative disease; Constipation; Tegaserod; Extrapyramidal syndrome